Lynne Bui
Director/Miembro de la Junta en THARIMMUNE, INC. .
Fortuna: - $ al 30/04/2024
Perfil
Lynne A Bui is the founder of Khloris Biosciences, Inc., Global Cancer Research Institute, GCRI Foundation, Inc. She is currently an Independent Director at Tharimmune, Inc. Her former positions include Chief Medical Officer at Onyx Pharmaceuticals, Inc., Exelixis, Inc., and Intellikine LLC.
She received her undergraduate degree from the University of California, Berkeley and her graduate degree from David Geffen School of Medicine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
THARIMMUNE, INC.
-.--% | 21/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Lynne Bui
| Empresas | Cargo | Inicio |
|---|---|---|
| THARIMMUNE, INC. | Director/Miembro de la Junta | 01/07/2021 |
Khloris Biosciences, Inc.
 Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | Director Ejecutivo | 01/06/2017 |
| Global Cancer Research Institute | Fundador | - |
| GCRI Foundation, Inc. | Fundador | - |
Antiguos cargos conocidos de Lynne Bui.
| Empresas | Cargo | Fin |
|---|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Director Técnico/Científico/I+D | - |
Intellikine LLC
 Intellikine LLC Pharmaceuticals: MajorHealth Technology Intellikine LLC develops and manufactures small molecule drugs for the treatment of cancer. The company focused on the development of potent, selective small molecule inhibitors of the PI3K/Akt/mTOR pathway for the treatment of cancer, inflammation and autoimmune disorders. Intellikine was founded on May 2nd, 2007 and is headquartered in La Jolla, CA. | Director Técnico/Científico/I+D | - |
| EXELIXIS, INC. | Director Técnico/Científico/I+D | - |
Formación de Lynne Bui.
| University of California, Berkeley | Undergraduate Degree |
| David Geffen School of Medicine | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| THARIMMUNE, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Intellikine LLC
Intellikine LLC Pharmaceuticals: MajorHealth Technology Intellikine LLC develops and manufactures small molecule drugs for the treatment of cancer. The company focused on the development of potent, selective small molecule inhibitors of the PI3K/Akt/mTOR pathway for the treatment of cancer, inflammation and autoimmune disorders. Intellikine was founded on May 2nd, 2007 and is headquartered in La Jolla, CA. | Health Technology |
Khloris Biosciences, Inc.
Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | Commercial Services |
| Global Cancer Research Institute | |
| GCRI Foundation, Inc. |
- Bolsa de valores
- Insiders
- Lynne Bui
